Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Barrett Esophagus × Radiofrequency Ablation × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 1 Barrett Esophagus 1 Adenocarcinoma Of Esophagus 1

Interventions

Specimen Handling 2 Biopsy 2 obeticholic acid 1 Radiofrequency Ablation 1 Itraconazole 1 Gastroscopy 1 Endoscopy, Digestive System 1 Endoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06732388 2026-03-18

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

National Cancer Institute (NCI)

Phase 2 Not yet recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡